Clinical Trial Update: iCaReMe Global Registry

View source ↗

Summary

AstraZeneca's iCaReMe Global Registry is currently recruiting participants for a study covering Type 2 diabetes mellitus, hypertension, chronic kidney disease, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure
• Hypertension
• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes, Hypertension | Status: RECRUITING